A 15 Week, Randomized, Double Blind, Parallel-group, Placebo-controlled, Flexible-dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
A 15 Week, Randomized, Double Blind, Parallel-group, Placebo-controlled, Flexible-dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia
This study will compare pregabalin with placebo over a 15 week period in adolescents with fibromyalgia aged 12-17 years to evaluate the safety and efficacy of pregabalin.
Inclusion Criteria:
Exclusion Criteria:
Worcester, Massachusetts 01655, United States
Philadelphia, Pennsylvania 19134-1095, United States
Charleston, South Carolina 29425, United States
Secunderabad, Andhra Pradesh 500 003, India
Nagpur, Maharashtra 440010, India